newsfilter
← Latest News
FDA Approved Drugs·

Approval of Bysanti, Nda #220358 (Type 1 - New Molecular Entity)

Approval Date: 02/20/2026; Drug Name: Bysanti, Nda #220358; Active Ingredients: MILSAPERIDONE; Company: Vanda Pharms Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 220358

Company
VANDA PHARMS INC
Keywords
VANDA PHARMS INC